SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-12-005490
Filing Date
2012-02-02
Accepted
2012-02-02 19:42:35
Documents
1
Period of Report
2012-01-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd332107.html 4  
1 FORM 4 rrd332107.xml 4 4012
  Complete submission text file 0001181431-12-005490.txt   5405
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Issuer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address RHEIN BIOTECH GMBH (DYNAVAX EUROPE) EICHSFELDER STR. 11 DUSSELDORF 2M 40595
Business Address
JANOWICZ ZBIGNIEW (Reporting) CIK: 0001427375 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34207 | Film No.: 12567583